The global Cardiac Marker Testing market gathered revenue around USD 3.0 Billion in 2020 and market is set to grow USD 7.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.9% during the prediction period 2021 to 2027. growth in the cardiac marker testing market is majorly driven by growing incidence of cardiovascular diseases, rapidly increasing geriatric population, and growing funding from public and private organizations for research on cardiac biomarkers.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Cardiac Marker Testing market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Cardiac Marker Testing market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Cardiac Marker Testing market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Point-of-care Testing (POCT) with cardiac biomarkers Opportunity:
In the past few years, the demand for point-of-care testing (POCT) assays has increased considerably, owing to the globally increasing number of cardiovascular disease patients in emergency departments (EDs) requiring urgent disease diagnosis. The adoption of POCT with cardiac biomarkers is growing in diagnostic procedures for cardiovascular diseases across the globe, owing to the advantages offered by it. These include reduced lengths of stay, improved emergency department efficiency, increased patient satisfaction and user experience, better turnaround times, and simpler sample collection. To capitalize on the opportunities in the POC segment, key industry players are increasingly focusing on developing technologically advanced POCT for cardiovascular diseases.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Cardiac Marker Testing Market are:
Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), bioMérieux SA (France), LSI Medience Corporation (Japan), Ortho Clinical Diagnostics (US), Randox laboratories Ltd. (UK), Guangzhou Wondfo Biotech Co., Ltd (China), DiaSorin S.p.A. (Italy), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Thermo Fisher Scientific Inc. (US), and Tosoh Corporation (Japan)
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product
- Reagents and Kits
- Instruments
- Chemiluminescence
- Immunofluorescence
- ELISA
- Immunochromatography
By Biomarker Type
- Troponin I and T
- CK-MB
- Bnp or Nt-Probnp
- Myoglobin
- Hscrp
- Other Biomarkers
By Disease
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Ischemia
By End User
- Laboratory Testing
- Hospital Labs
- Reference Labs
- Contract Testing Labs
By Geography
North America
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Download Sample
Request Customization
Request Customization
Download Sample
